Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
SAN DIEGO, May 8, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that the company's management will present a corporate overview at the following investment conferences during the month of May:
- Bank of America Merrill Lynch 2013 Health Care Conference at the Encore at the Wynn Hotel in Las Vegas on Wednesday, May 15, 2013 at 2:20pm Pacific Time (5:20pm Eastern Time).
- UBS Global Healthcare Conference 2013 at the Sheraton New York Hotel in New York City on Tuesday, May 21 at 2:00pm Eastern Time (11:00am Pacific Time).
- Deutsche Bank's 38th Annual Health Care Conference at the Westin Boston Waterfront Hotel in Boston on Thursday, May 30, 2013 at 11:20am Eastern Time (8:20am Pacific Time).
Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com in the Investor Relations section. A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. For more information about Cadence, please visit www.cadencepharm.com.
William R. LaRue
Cadence Pharmaceuticals, Inc.
SOURCE Cadence Pharmaceuticals, Inc.
More by this Source
Cadence Pharmaceuticals Reports Positive Outcome In OFIRMEV® Patent Litigation
Nov 14, 2013, 18:54 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.